Eluxadoline
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
Diarrhea-predominant irritable bowel syndrome treatment options eluxadoline, rifaximin, and alosetron: analysis of the FDA adverse event reporting system (FAERS) database.
Journal: Expert opinion on drug safety
Published: April 08, 2025
The Safety of Pharmacotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
Journal: The American journal of gastroenterology
Published: February 25, 2025
Comparison chart: Safety of drugs for IBS in pregnancy and lactation.
Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2025
Comparison chart: Some drugs for irritable bowel syndrome with diarrhea (IBS-D).
Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2025
Drugs for irritable bowel syndrome.
Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2025
Figure 1: Treatments for irritable bowel syndrome (IBS) in adults.
Journal: The Medical letter on drugs and therapeutics
Published: February 06, 2025
An evidence-based update on the diagnosis and management of irritable bowel syndrome.
Journal: Expert review of gastroenterology & hepatology
Published: January 21, 2025
A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and Evidence.
Journal: Journal of clinical medicine
Published: October 26, 2024
Visceral analgesic effect of eluxadoline (Viberzi): A central action.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 25, 2024
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review.
Journal: Archiv der Pharmazie
Published: May 08, 2024
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new?
Journal: Expert opinion on drug metabolism & toxicology
Published: April 26, 2024
Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs.
Journal: Expert opinion on investigational drugs
Published: February 17, 2024
Last Updated: 02/24/2026